Structure-Based Evolution of Low Nanomolar O‑GlcNAc Transferase Inhibitors
Reversible glycosylation of nuclear and cytoplasmic proteins is an important regulatory mechanism across metazoans. One enzyme, O-linked N-acetylglucosamine transferase (OGT), is responsible for all nucleocytoplasmic glycosylation and there is a well-known need for potent, cell-permeable inhibitors...
Saved in:
Published in | Journal of the American Chemical Society Vol. 140; no. 42; pp. 13542 - 13545 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Chemical Society
24.10.2018
American Chemical Society (ACS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Reversible glycosylation of nuclear and cytoplasmic proteins is an important regulatory mechanism across metazoans. One enzyme, O-linked N-acetylglucosamine transferase (OGT), is responsible for all nucleocytoplasmic glycosylation and there is a well-known need for potent, cell-permeable inhibitors to interrogate OGT function. Here we report the structure-based evolution of OGT inhibitors culminating in compounds with low nanomolar inhibitory potency and on-target cellular activity. In addition to disclosing useful OGT inhibitors, the structures we report provide insight into how to inhibit glycosyltransferases, a family of enzymes that has been notoriously refractory to inhibitor development. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 National Institutes of Health (NIH) Present Addresses Chemistry Department, The College of Wooster, 931 College Mall, Wooster, OH 44691 Department of Molecular and Cellular Pharmacology, Stanford University School of Medicine, Stanford, CA 94305, USA |
ISSN: | 0002-7863 1520-5126 1520-5126 |
DOI: | 10.1021/jacs.8b07328 |